Intrathecal magnetic drug targeting to the central nervous system with superparamagnetic nanoparticles
使用超顺磁性纳米颗粒靶向中枢神经系统的鞘内磁性药物
基本信息
- 批准号:1403409
- 负责人:
- 金额:$ 29.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-01 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Proposal Number: CBET - 1403409 Principal Investigator: Andreas A. LinningerInstitution: University of Illinois at ChicagoTitle: Intrathecal magnetic drug targeting to the central nervous system with superparamagnetic nanoparticlesFor a family of diseases of the central nervous system (CNS), especially brain tumors and spinal metastases, few effective treatment options exist. Existing treatments have serious side effects including acute pain, nausea and even paralysis, due to lack of a targeted drug delivery strategy. In order to localize drug molecules in specific diseased target sites within the CNS, the investigator proposes a novel nanoparticle drug delivery technique termed Intrathecal Magnetic Drug Targeting (IT-MDT). It combines traditional intrathecal drug administration with magnetic drug targeting for highly localized treatment of neurological disorders. In this technique, magnetic nanoparticles (MNPs) conjugated to therapeutic agents are directly infused into the cerebrospinal fluid (CSF) and collected at the desired target site via an external magnetic field. The drug then desorbs from the MNPs to begin its therapeutic mechanism of action. The most notable benefit of MDT resides in highly confined local drug action in the desired region such as the tumor site. At the same time, systemic side effects are minimal because of the limited drug spread. The project will advance the fundamental understanding of magnetically targeted nanoparticle transport within the CNS and develop fundamental insights about biotransport phenomena within the intrathecal space. This study will also create intellectual advancements necessary to elevate MNP based carriers from a research subject to a clinically useful technology.The Blood Brain Barrier (BBB) regulates molecular transport and protects the CNS against harmful compounds, but also hinders therapeutic interventions by preventing drugs from reaching the brain or spinal cord. Therefore, there is a critical need for developing drug delivery techniques for guiding and localizing therapeutic agents at specific target cells in the CNS. The proposed IT-MDT delivery technique uses magnetic forces to guide and confine intrathecally delivered, superparamagnetic drug functionalized MNPs to any desired target location within the CNS. This mode of drug administration offers the following advantages: it (i) bypasses the BBB, (ii) reduces toxicity while enhancing treatment efficiency in the target site, and (iii) enables active external control over the spatial and temporal distribution of the drug inside the CNS. To establish this novel mechanism, it is planned to (1)design and synthesize magnetic nanoparticle based drug delivery vehicles, (2) conduct IT-MDT experiments in a physiologically relevant 3D live cell spine model,(3) perform IT-MDT treatment of in vitro spinal cord tumors using doxorubicin loaded magnetic nanoparticles. This study will establish a novel technique for effectively conjugating tumor drug molecules to MNPs, build and validate a 3D live tumor cell spine model to demonstrate cellular uptake and tumor cell death from the drug functionalized nanoparticles. The experiments will study cellular uptake of MNPs at the cerebrospinal fluid (CSF)-pia interface in the presence of pulsatile CSF motion and eddies caused by the spinal micro-anatomy. The results will enable to select critical parameters such as MNP infusate concentration, flow rate and duration to achieve desired therapeutic concentrations of MNPs at specific target locations along the CNS. Optimal magnetic field parameters for steering nanoparticles to desired locations in the CNS will be established both by experiments and by computational fluid dynamic methods and magnetostatics.This award by the Biotechnology, Biochemical, and Biomass Engineering Program of the CBET Division is co-funded by the Instrument Development for Biological Research Program of the Division of Biological Infrastructure.
提案编号:CBET - 1403409主要研究者:Andreas A. Linninger机构:题目:利用超顺磁性纳米粒子靶向中枢神经系统的鞘内磁性药物对于中枢神经系统(CNS)疾病家族,尤其是脑肿瘤和脊柱转移瘤,几乎没有有效的治疗选择。现有的治疗方法有严重的副作用,包括急性疼痛,恶心,甚至瘫痪,由于缺乏有针对性的药物输送策略。为了将药物分子定位在中枢神经系统内特定的疾病靶点,研究人员提出了一种新型纳米颗粒药物递送技术,称为鞘内磁性药物靶向(IT-MDT)。它将传统的鞘内给药与磁性药物靶向结合起来,用于神经系统疾病的高度局部化治疗。在该技术中,将与治疗剂缀合的磁性纳米颗粒(MNP)直接注入脑脊液(CSF)中,并通过外部磁场在所需的靶部位收集。然后药物从MNP上解吸,开始其治疗作用机制。MDT最显著的益处在于在所需区域(如肿瘤部位)中高度限制的局部药物作用。同时,由于药物扩散有限,全身副作用很小。 该项目将推进对CNS内磁靶向纳米颗粒运输的基本理解,并开发有关鞘内空间内生物运输现象的基本见解。这项研究还将创造必要的智力进步,以提高MNP为基础的载体从一个研究课题,临床上有用的technology.The血脑屏障(BBB)调节分子运输和保护中枢神经系统免受有害化合物,但也阻碍了治疗干预,阻止药物到达大脑或脊髓。因此,迫切需要开发用于将治疗剂引导和定位在CNS中的特定靶细胞处的药物递送技术。所提出的IT-MDT递送技术使用磁力来引导和限制鞘内递送的超顺磁性药物功能化的MNP至CNS内的任何期望的靶位置。这种给药模式具有以下优点:(i)绕过BBB,(ii)降低毒性,同时提高靶部位的治疗效率,以及(iii)能够对药物在中枢神经系统内的空间和时间分布进行主动外部控制。为了建立这种新的机制,计划(1)设计和合成基于磁性纳米颗粒的药物递送载体,(2)在生理学相关的3D活细胞脊柱模型中进行IT-MDT实验,(3)使用多柔比星负载的磁性纳米颗粒进行体外脊髓肿瘤的IT-MDT治疗。 本研究将建立一种将肿瘤药物分子有效地结合到MNP上的新技术,建立并验证三维活肿瘤细胞脊柱模型,以证明药物功能化纳米颗粒的细胞摄取和肿瘤细胞死亡。实验将研究在存在由脊柱显微解剖结构引起的脉动CSF运动和涡流的情况下,在脑脊液(CSF)-软脑膜界面处的MNP的细胞摄取。结果将使得能够选择关键参数,例如MNP输注液浓度、流速和持续时间,以在沿着CNS的特定靶位置沿着达到所需的MNP治疗浓度。将通过实验和计算流体动力学方法以及静磁学来建立将纳米粒子引导到CNS中所需位置的最佳磁场参数。CBET部门的生物技术,生物化学和生物质工程计划的这项奖励由生物基础设施部门的生物研究计划仪器开发共同资助。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andreas Linninger其他文献
Batch process development: From reactions to manufacturing systems
- DOI:
10.1016/s0098-1354(99)80232-4 - 发表时间:
1999-06-01 - 期刊:
- 影响因子:
- 作者:
George Stephanopoulos;Shahin Ali;Andreas Linninger;Enrique Salomone - 通讯作者:
Enrique Salomone
Image-guidance technology and the surgical resection of spinal column tumors
- DOI:
10.1007/s11060-016-2325-4 - 发表时间:
2016-11-28 - 期刊:
- 影响因子:3.100
- 作者:
Bhargav Desai;Jonathan Hobbs;Grant Hartung;Guoren Xu;Ziya L. Gokaslan;Andreas Linninger;Ankit I. Mehta - 通讯作者:
Ankit I. Mehta
Current status of intratumoral therapy for glioblastoma
- DOI:
10.1007/s11060-015-1875-1 - 发表时间:
2015-08-02 - 期刊:
- 影响因子:3.100
- 作者:
Ankit I. Mehta;Andreas Linninger;Maciej S. Lesniak;Herbert H. Engelhard - 通讯作者:
Herbert H. Engelhard
Andreas Linninger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andreas Linninger', 18)}}的其他基金
Computational platform for predictive magnetohydrodynamic drug targeting
预测磁流体动力学药物靶向计算平台
- 批准号:
1706921 - 财政年份:2017
- 资助金额:
$ 29.88万 - 项目类别:
Standard Grant
EAGER: Computational investigation of the distributed decentralized control of cerebral blood flow
EAGER:脑血流分布式分散控制的计算研究
- 批准号:
1301198 - 财政年份:2013
- 资助金额:
$ 29.88万 - 项目类别:
Standard Grant
RET in Engineering and Computer Science Site - Chicago Science Teacher Research (CSTR) Program
工程和计算机科学领域的 RET - 芝加哥科学教师研究 (CSTR) 计划
- 批准号:
1132694 - 财政年份:2012
- 资助金额:
$ 29.88万 - 项目类别:
Continuing Grant
Novel Processes and Materials in Bioengineering and Biomedical Engineering
生物工程和生物医学工程中的新工艺和新材料
- 批准号:
0754590 - 财政年份:2008
- 资助金额:
$ 29.88万 - 项目类别:
Standard Grant
Interstitial dynamics of the poroelastic brain and cerebral vasculature in humans
人体多孔弹性脑和脑血管系统的间质动力学
- 批准号:
0756154 - 财政年份:2008
- 资助金额:
$ 29.88万 - 项目类别:
Continuing Grant
Chicago Science Teacher Research (CSTR) Program
芝加哥科学教师研究 (CSTR) 计划
- 批准号:
0743068 - 财政年份:2007
- 资助金额:
$ 29.88万 - 项目类别:
Standard Grant
Collabortive Research: Mathematical optimization for targeted macro-molecules delivery to the brain
协作研究:将目标大分子输送到大脑的数学优化
- 批准号:
0730048 - 财政年份:2007
- 资助金额:
$ 29.88万 - 项目类别:
Standard Grant
Integrated Design and Control Under Uncertainty
不确定性下的集成设计与控制
- 批准号:
0626162 - 财政年份:2006
- 资助金额:
$ 29.88万 - 项目类别:
Standard Grant
Chicago Science Teacher Research (CSTR) Program
芝加哥科学教师研究 (CSTR) 计划
- 批准号:
0502272 - 财政年份:2005
- 资助金额:
$ 29.88万 - 项目类别:
Standard Grant
Clean Batch Manufacturing with Uncertainty Management (TSE03-K)
具有不确定性管理的清洁批量制造 (TSE03-K)
- 批准号:
0328134 - 财政年份:2003
- 资助金额:
$ 29.88万 - 项目类别:
Standard Grant
相似国自然基金
基于慧眼-HXMT宽能段观测的X射线吸积脉冲星磁场研究
- 批准号:12373051
- 批准年份:2023
- 资助金额:55.00 万元
- 项目类别:面上项目
磁性薄膜和磁性纳米结构中的自旋动力学研究
- 批准号:11174131
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
补偿性还是非补偿性规则:探析风险决策的行为与神经机制
- 批准号:31170976
- 批准年份:2011
- 资助金额:64.0 万元
- 项目类别:面上项目
精神分裂症进程中非对称性活跃脑结构改变的磁共振研究
- 批准号:81171275
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
基于多模态磁共振探索迟发性运动障碍神经环路结构和功能异常
- 批准号:81100999
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
精神分裂症记忆障碍的脑网络组学研究
- 批准号:91132301
- 批准年份:2011
- 资助金额:350.0 万元
- 项目类别:重大研究计划
基于非血流信号的脑功能成像技术与探测研究
- 批准号:81071149
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
一种新的给药方式--耳后给药治疗内耳疾病的作用途径及机制研究
- 批准号:81070780
- 批准年份:2010
- 资助金额:28.0 万元
- 项目类别:面上项目
超顺磁性氧化铁-量子点双显像荷电量可控性正电荷纳米囊泡用于干细胞移植的MRI活体示踪
- 批准号:81071208
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
磁力显微镜对纳米尺度磁畴结构的定量研究
- 批准号:51071088
- 批准年份:2010
- 资助金额:38.0 万元
- 项目类别:面上项目
相似海外基金
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease
鞘内环糊精治疗猫 C 型尼曼匹克病
- 批准号:
8447003 - 财政年份:2011
- 资助金额:
$ 29.88万 - 项目类别:
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease
鞘内环糊精治疗猫 C 型尼曼匹克病
- 批准号:
8084588 - 财政年份:2011
- 资助金额:
$ 29.88万 - 项目类别:
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease
鞘内环糊精治疗猫 C 型尼曼匹克病
- 批准号:
8820838 - 财政年份:2011
- 资助金额:
$ 29.88万 - 项目类别:
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease
鞘内环糊精治疗猫 C 型尼曼匹克病
- 批准号:
8235857 - 财政年份:2011
- 资助金额:
$ 29.88万 - 项目类别:
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease
鞘内环糊精治疗猫 C 型尼曼匹克病
- 批准号:
8629803 - 财政年份:2011
- 资助金额:
$ 29.88万 - 项目类别:
INTRATHECAL INTERFERON AS THERAPY FOR MULTIPLE SCLEROSIS
鞘内注射干扰素治疗多发性硬化症
- 批准号:
3399769 - 财政年份:1983
- 资助金额:
$ 29.88万 - 项目类别:
An Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in Mucopolysaccharidosis I
鞘内酶替代治疗粘多糖贮积症 I 型认知衰退的推广研究
- 批准号:
8907060 - 财政年份:
- 资助金额:
$ 29.88万 - 项目类别:
An Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in Mucopolysaccharidosis I
鞘内酶替代治疗粘多糖贮积症 I 型认知衰退的推广研究
- 批准号:
9557579 - 财政年份:
- 资助金额:
$ 29.88万 - 项目类别:
An Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in Mucopolysaccharidosis I
鞘内酶替代治疗粘多糖贮积症 I 型认知衰退的推广研究
- 批准号:
8934174 - 财政年份:
- 资助金额:
$ 29.88万 - 项目类别:
An Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in Mucopolysaccharidosis I
鞘内酶替代治疗粘多糖贮积症 I 型认知衰退的推广研究
- 批准号:
9338314 - 财政年份:
- 资助金额:
$ 29.88万 - 项目类别: